Persistent Asset Partners Ltd

SEC CIK: 0002056052
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

CADL holding history

Candel Therapeutics, Inc. in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CADL overview All 13F holders of CADL Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of CADL by Persistent Asset Partners Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−5,918−100.0%	Sold out	Holders
Q1 2025	5,918	$33.4K	<0.1%	−128−2.1%	Reduced	Holders
Q4 2024	6,046	$42.7K	<0.1%	–	No prior filing	Holders